Intelligent Bio Solutions Inc. SEC filings INBS
Intelligent Bio Solutions Inc. has 467 filings in SEC EDGAR's recent list, going back to Dec 29, 2017. Its latest annual report, Form ARS, was filed on Nov 2, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 13, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Oct 13, 2026 (bylaw or fiscal year change, regulation fd disclosure). The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Nov 2, 2026 | Nov 2, 2026 |
| PRE 14A | Preliminary proxy statement | Oct 23, 2026 | Oct 23, 2026 |
| DEF 14A | Proxy statement | Sep 19, 2025 | Sep 19, 2025 |
| PRE 14A | Preliminary proxy statement | Sep 9, 2025 | Sep 9, 2025 |
| DEFA14A | Additional proxy material | Apr 29, 2025 | — |
| DEFA14A | Additional proxy material | Apr 28, 2025 | — |
| DEF 14A | Proxy statement | Apr 1, 2025 | Apr 1, 2025 |
| DEF 14A | Proxy statement | Nov 16, 2023 | Nov 16, 2023 |
| PRE 14A | Preliminary proxy statement | Nov 6, 2023 | Nov 6, 2023 |
| DEF 14A | Proxy statement | Oct 20, 2023 | Oct 20, 2023 |
| PRE 14A | Preliminary proxy statement | Oct 10, 2023 | Oct 10, 2023 |
| DEF 14A | Proxy statement | Apr 10, 2023 | Apr 10, 2023 |
| PRE 14A | Preliminary proxy statement | Mar 29, 2023 | Mar 29, 2023 |
| DEF 14A | Proxy statement | Jan 4, 2023 | Jan 4, 2023 |
| PRE 14A | Preliminary proxy statement | Dec 23, 2022 | Dec 23, 2022 |
| DEFA14A | Additional proxy material | Jul 14, 2022 | — |
| DEFA14A | Additional proxy material | Jun 27, 2022 | — |
| DEFA14A | Additional proxy material | Jun 16, 2022 | — |
| DEF 14A | Proxy statement | May 6, 2022 | May 5, 2022 |
| PRE 14A | Preliminary proxy statement | Apr 26, 2022 | Apr 26, 2022 |
Showing 20 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- INBS (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1725430
- Former names
- GBS Inc. (until Oct 18, 2022); Glucose Biosensor Systems (Greater China) Holdings, Inc. (until Sep 19, 2019)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.